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parents were primarily Spanish-speaking; 40% completed the
Spanish version of the survey, and 84% identiﬁed as Hispanic. The
Cronbach’s alpha for the 5-item scale was 0.71. Cronbach alphawas
different when stratifying for demographic variables; most notably
higher for those using the Spanish vs English version (0.76
vs. 0.64), for those who spoke English vs Spanish at home (0.79 vs.
0.68), and for those with annual household incomes above vs.
below $50,000 (0.81 vs. 0.71).
Conclusions: The modiﬁed trust scale for SLIP(s) showed adequate
internal consistency among a sample of predominately Hispanic
parents of middle school students. However, internal consistency
of this scale was lower among Spanish speakers than English
speakers and those with higher incomes. In addition, among this
primarily Hispanic population, the Spanish version of the survey
demonstrated higher internal consistency. These data suggest a
need to further evaluate andmodify this scale for populations with
signiﬁcant variation in language variables and socioeconomic
status.
Sources of Support: SAHM Public Demonstration Grants through
Merck.158.
PARENTAL ATTITUDES AND BELIEFS ABOUT HUMAN
PAPILLOMAVIRUS (HPV) VACCINATION AND VACCINE RECEIPT
AMONG ADOLESCENTS IN RICHMOND COUNTY, GEORGIA
Natasha Herbert, MPH.
Emory University School of Medicine.
Purpose: The Advisory Committee on Immunization Practices
currently recommends human papillomavirus vaccination (HPV)
for males and females ages 9-26 years. Parental attitudes can often
inﬂuence health decisions, especially those involving vaccines for
their adolescents. We investigated parental attitudes and beliefs
about human papillomavirus vaccination as well as parental self-
reported receipt and series completion for their adolescent. The
HPV vaccine series requires three doses, an initial vaccination, a
second vaccination 2 months after initial dose and a third vacci-
nation six months after initial dose.
Methods: We conducted a three-arm cluster-randomized
controlled trial in middle and high schools in Richmond County,
Georgia over three years. 11 schools were randomly assigned to one
of three treatment arms: Arm 1) No Intervention; Arm 2) an
educational brochure about adolescent vaccines mailed home for
parents; and Arm 3) a curriculum delivered by teachers in class-
rooms of adolescents and an educational brochure for parents.
Students received the intervention to which the school was
assigned. Parents in all arms were surveyed annually to assess at-
titudes and beliefs about the four recommended adolescent vacci-
nations (yearly seasonal inﬂuenza, meningococcal conjugate,
tetanus, diphtheria and pertussis and HPV vaccines), as well as self-
report of vaccine receipt by their adolescent. Survey topics included
perceived susceptibility, perceived severity and perceived beneﬁts
about their child receiving the HPV vaccine. The surveys were
administered before delivery of the interventions, Year 1 and in
Years 2 and 3. Surveys were administered via telephone and online.
Six attitude and belief questions about HPV vaccination were
compiled into an attitude scale ranging from 0-6, where 0 means no
positive attitudes about HPV vaccination and 6 means respondentsindicated very positive attitudes about HPV vaccination. Chi-square
tests were performed using SPSS to assess differences.
Results: We identiﬁed 686 parents in total from the three inter-
vention arms (Arm1 n¼ 210, Arm 2 n¼ 251, Arm 3 n¼ 225). Results
show a range of opinions about HPV vaccination with participants
receiving a score of 0 (3.8%), 1 (5.4%), 2 (8.2%), 3 (21.1%), 4 (20.3%), 5
(28%) or 6 (13.3%). Approximately half (48%) of parents reported that
their adolescent received at least one dose of HPV vaccine. Higher
scores on the attitude and belief scale were associated with the
receipt of HPV vaccine (p< .001). Among parents whose adolescent
initiated the series, 61% (n ¼ 206) were reported to have completed
the three dose series. However, there was no statistically signiﬁcant
association between parental attitudes and series completion.
Conclusions: Parents in our sample showed positive attitudes and
beliefs about HPV vaccine. 62% of parents scored 4 or greater on the
attitudinal scale. These favorable opinions about the HPV vaccine
were associated with initial vaccine receipt as reported by parents.
Future efforts should be made to promote the beneﬁts of HPV
vaccination through sources of information that parents trust.
Novel and innovative methods could potentially aid in increasing
the rate of series completion among this population.
Sources of Support: This project is funded by the Centers for
Disease Control and Prevention grant U011P000413.
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VACCINATION RATES: A QUALITATIVE STUDY
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Justen Sumner, Ignacio DeLaCruz, MPH, Jessica Vercruysse, MPH,
Caroline Finlay, Natalie Pierre-Joseph, MD, MPH, FSAHM.
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Purpose: To understand why parents do not initiate the HPV
vaccine series for their daughters, and to see how these reasons
differ in parents of different races, ethnicities, countries of origin,
socioeconomic status, and public safety net vs. private practice
clinical settings.
Methods:We approached parents accompanying 11-17 year old
daughters to medical visits in one public safety net hospital
and three private practice settings. We performed semi-struc-
tured qualitative interviews with parents to determine the
primary reasons why their daughters had not started the
vaccine series. Interviews were performed in English, Spanish,
and Haitian-Creole. Interviews were coded using qualitative
methods to identify and evaluate recurring themes. Answers
were compared across race/ethnicity, socioeconomic status,
and practice settings (public or private), to determine differ-
ences in attitudes, perceptions, parent-provider communica-
tion, and primary reasons for not initiating vaccination.
Electronic medical records were reviewed to conﬁrm vaccina-
tion status.
Results: 47 parents believed that their daughters had not
initiated HPV vaccination; 38 were unvaccinated on medical
record review, and these transcripts were analyzed. Nine par-
ents self-identiﬁed as Black (including African-Americans and
African and Caribbean immigrants), 19 White, 8 Latino, and 2
other races. 14 parents were immigrants and 27 expressed a
religious afﬁliation. Family income ranged from < $20,000 to >
$100,000 annually. Parents’ level of knowledge about HPV
vaccination varied from almost none to very detailed
Poster Presentations / 54 (2014) S34eS93 S83knowledge about transmission, HPV related cancers and genital
diseases, and vaccine efﬁcacy. The most common reason parents
reported for not vaccinating their daughters was the lack of a
physician recommendation (44%), which represents missed
opportunities, as all daughters were eligible for vaccination. The
remaining parents declined vaccination because they lacked
information (21%), felt that their daughters were too young
(13%), had safety concerns (11%), believed that vaccination was
unnecessary due to abstinence (5%), or worried that vaccination
could promote unsafe sexual practices (3%). Girls who were not
offered the vaccine were younger on average than those who
declined vaccination (12  1.3 vs. 13.5  1.8, p ¼ 0.01). Race,
country of origin, religious afﬁliation, income, private vs. public
clinic site, and knowledge did not differ between those who
declined vaccination and those who were not offered
vaccination.
Conclusions: Missed opportunities by clinicians were the most
common reason for non-initiation of vaccination in this diverse
cohort, and was especially common for girls ages 11-12, for
whom routine vaccination is recommended. Most parents who
declined vaccination expressed a desire for information on in-
dications, efﬁcacy, and safety. Education of both parents and
physicians on the rationale for vaccination at ages 11-12 can
improve uptake.
Sources of Support: Centers for Disease Control and Prevention,
UO1 grant #IP000636-01. American Cancer Society Mentored
Research Scholar Grant #MRSG-09-151-01. American Cancer So-
ciety Cancer Control Career Development Award for Primary Care
Physician #CCCDA-10-086-01.
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STAYING AHEAD OF THE RACE: HPV IMMUNIZATION IN BOYS
AND GIRLS ACROSS AN URBAN AND SUBURBAN HEALTHCARE
SYSTEM
Neelab Abdullah 1, Connie Chen 2, Jennae McCulley 1, Harjoat Singh 1,
Samantha DeMarsh 1, Sarah Worley, MS 3, Kim Giuliano, MD 4,
Ellen S. Rome, MD, MPH 3.
1Cleveland Clinic Summer Research Intern Program; 2Cleveland Clinic
Summer Intern Program; 3Cleveland Clinic; 4Cleveland Clinic
Children’s Hospital.
Purpose: Human papillomavirus (HPV) is the most common
sexually transmitted infection in adolescents, occurring in 1
million 15- 19 year olds annuallyCurrent guidelines recommend
vaccination for girls (ages 9-26 years) and boys (11-26 years)
beginning at age 11-12 years, with catch up immunizations if
started later. In the USA, HPV vaccination rates are low: 53% for
girls and 8% for boys, with only 35% of girls and 1% of boys
completing the series (CDC 2011).
Hypothesis: A large health system with electronic medical re-
cords (EMR) and a wellness oriented patient population should
have higher HPV vaccination rates than the national average. Prior
attitudinal survey from within our health system found higher
intention to vaccinate in urban, indigent settings than in suburban,
afﬂuent sites (Gillespie et al 2011); in our population, urban set-
tings are expected to have higher immunization rates than sub-
urban sites.
Methods: A sampling of 5,355 out of 15,322 patients seen for well
visits across 15 suburban family health centers and 3 urban centers
were evaluated by retrospective chart review. Data was de-identiﬁed and included birthdate, gender, primary care provider,
location of provider, and vaccination initiation and completion. If
vaccinated, the dates, prescribing physician and health center
location were recorded for each dose. Data was entered into
REDCap and analyzed using JMP Pro 10.0.
Results: Charts of 2893 girls (mean + SD current age: 20+3.3) and
2462 boys (mean + SD current age: 20+3.1) were reviewed. HPV
vaccine series initiation/completion rates were signiﬁcantly better
than the national averages: 1844 (64%) girls,489 (20%) boys
received at least one dose of HPV vaccine, and 51% girls, 8.6% boys
completed the series (P < 0.001 for all comparisons). 17% of girls
(N ¼ 494) and 10% (N ¼ 244) of boys received primary care at an
urban site. Initiation of series occurred at a mean age of 16.0 years
(range 10.5-26.5) versus 16.5 years (10.3-25.1, p ¼ 0.002) for sub-
urban versus urban girls, and 17.4 years for suburban boys (range
13.1-23.7) and 17.6 years for urban boys (13.8-23.3, p ¼ 0.23).
Compared to suburban sites, urban sites had signiﬁcantly higher
vaccine initiation rates among both girls (79% vs. 61%, P < 0.001)
and boys (37% vs. 18%, P < 0.001). Completion of series was
documented for 67% of urban vs 48% of suburban girls (p < 0.001),
and for 13% of urban vs. 8% of suburban boys (p ¼ 0.019). Among
those who initiated vaccination, completion of series was docu-
mented for 86% of urban vs 79% of suburban girls (p ¼ 0.005), and
for 34% of urban vs. 45% of suburban boys (p ¼ ¼ 0.068).
Conclusions: HPV vaccination rates within a health systemwith an
EMR are higher than the national average for boys and girls, with
urban sites more successful at vaccination initiation and comple-
tion than suburban sites. Limitations of our sample include pa-
tients leaving the health system and completing vaccination
elsewhere, as well as variabilities in sample size across sites.
Sources of Support: None.
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SOMATIC SYMPTOMS DURING ADOLESCENCE: DOES PARENTING
STYLE PLAY A ROLE?
Rachel S. White, PhD, Constance Wiemann, PhD, Beth Garland, PhD.
Baylor College of Medicine.
Purpose: A positive relationship exists between anxious and
depressive symptoms and somatic symptoms in children and ad-
olescents. Somatic symptoms have been associated with physical
discomfort, poor school attendance, social difﬁculties, and frequent
medical visits. Prevalence studies suggest that in youth, somatic
symptoms are most common within adolescent samples. In one
study, 23% of 13 to 17 year olds reported somatic symptoms over
a one year period (compared to 13% of 2 to 6 year olds and 17% of
7 to 12 year olds). Thus, interventions aimed at decreasing such
symptoms among adolescents are important. Behavioral in-
terventions taught directly to the patient are common. Little is
known about other systems within a child’s environment and the
role they play in the development or maintenance of somatic
symptoms. It may be that behavioral interventions could be more
effective if augmented with speciﬁc parenting strategies. The cur-
rent study examined ways in which different parenting styles (e.g.,
authoritarian, authoritative, and permissive) relate to somatic
symptoms in adolescents experiencing anxious or depressive
symptoms. Understanding parenting styles and how they relate to
